© Copyright - Newspaper WordPress Theme by TagDiv
Moxifloxacin Hydrochloride
Also known as / Synonyms: Moxifloxacin Ophthalmic, 4th-Gen Fluoroquinolone Eye Drops
Fourth-generation antibiotic eye drops that rapidly clear bacterial conjunctivitis (pink eye) and prevent eye infections after surgery.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment of bacterial conjunctivitis (pink eye) caused by susceptible strains of Gram-positive, Gram-negative, and atypical bacteria.
- Treatment of bacterial keratitis (corneal ulcers) and blepharitis.
- Pre-operative and post-operative prophylaxis of bacterial endophthalmitis in patients undergoing cataract, LASIK, or intraocular surgery.
- Prevention of secondary bacterial infection following corneal abrasions, foreign body removal, or ocular trauma.
Contraindications (Do Not Use If…)
- Known hypersensitivity to moxifloxacin, other fluoroquinolones, or formulation components.
- Viral (herpetic keratitis), fungal, or parasitic ocular infections.
Important Clinical Precautions & Warnings
- Do not touch dropper tip to eye: avoid contaminating the dropper tip with eyelids or fingers.
- Do not wear contact lenses: contact lens wear is contraindicated during active bacterial conjunctivitis or keratitis; wait until infection has completely cleared before resuming lenses.
- Complete the full course: standard course is 1 drop in the affected eye 3 times daily for 7 days; stopping early promotes resistant bacterial superinfections.
- Superior corneal penetration: possesses higher lipophilicity and superior ocular tissue penetration compared to older fluoroquinolones (ciprofloxacin, ofloxacin), achieving therapeutic levels in the anterior chamber.
- Self-preserved formulation: commercial 0.5% moxifloxacin solutions are formulated without benzalkonium chloride (BAK), making them less toxic to the corneal epithelium.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Approved for infants and children aged 1 year and older for bacterial conjunctivitis. Geriatric: Safe and standard therapy; highly effective for post-cataract surgery surgical prophylaxis.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Transient eye irritation, mild stinging/burning upon instillation, dry eyes, subconjunctival hemorrhage, and blurred vision.
Serious Side Effects — Seek Urgent Medical Care
Severe corneal melting/perforation (in severe untreated keratitis), fungal superinfection, hypersensitivity angioedema, and anaphylaxis.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- No significant systemic drug interactions with topical ophthalmic use.
- Separate instillation from other eye drops by at least 5 minutes.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Systemic absorption from ophthalmic instillation is clinically negligible. Topical moxifloxacin eye drops are considered safe to use for acute bacterial eye infections during pregnancy.
Lactation & Breastfeeding:
Excretion in human milk following eye drops is undetectable. It is safe for nursing mothers.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store between 15°C and 25°C (59°F to 77°F). Discard bottle 4 weeks after opening.
⏱️ Missed Dose Protocol:
Instill 1 drop as soon as remembered. If close to the next scheduled dose, skip and resume regular 3-times-daily routine. Do not instill extra drops.
Accidental ingestion of a 5 mL bottle contains only 25 mg of moxifloxacin (a fraction of standard 400 mg oral dose) and poses no systemic toxicity risk. Provide oral fluids.
